What adjuvant treatment (if any) would you recommend for a post-menopausal patient with a borderline T1b (0.5 cm) grade 2 ER+/PR+/HER2 negative invasive lobular breast CA after bilateral mastectomies?

1 Answers

Mednet Member

Medical Oncology · Mayo Clinic Rochester

My evaluation and plan for any patient with breast cancer seen in the Stage 0-3 setting tends to follow a similar pattern. The risks include:

Distant recurrence
Local recurrence
New breast primaries
Side effects of therapy

The systemic therapy options for lowering these 3 categories of risk in this ...

What adjuvant treatment (if any) would you recommend for a post-menopausal patient with a borderline T1b (0.5 cm) grade 2 ER+/PR+/HER2 negative invasive lobular breast CA after bilateral mastectomies? | Mednet